1. Schoggins, John W, Wilson, Sam J, Panis, Maryline, Bieniasz, Paul, Rice, Charles M. 2011. A diverse range of gene products are effectors of the type I interferon antiviral response. In Nature, 472, 481-5. doi:10.1038/nature09907. https://pubmed.ncbi.nlm.nih.gov/21478870/
2. Wang, Haipeng, Wang, Li, Luo, Xiaolin, Zhang, Ling, Xiang, Yi. 2022. Molecular characterization, expression and anti-tumor function analysis of yak IFITM2 gene. In International journal of biological macromolecules, 209, 405-412. doi:10.1016/j.ijbiomac.2022.03.212. https://pubmed.ncbi.nlm.nih.gov/35381283/
3. Chen, Lei, Li, Xiangrong, Deng, Yingying, Xie, Jingying, Feng, Ruofei. 2023. IFITM2 Presents Antiviral Response through Enhancing Type I IFN Signaling Pathway. In Viruses, 15, . doi:10.3390/v15040866. https://pubmed.ncbi.nlm.nih.gov/37112847/
4. Daniel-Carmi, Vered, Makovitzki-Avraham, Efrat, Reuven, Eliran-Moshe, Tzehoval, Esther, Eisenbach, Lea. . The human 1-8D gene (IFITM2) is a novel p53 independent pro-apoptotic gene. In International journal of cancer, 125, 2810-9. doi:10.1002/ijc.24669. https://pubmed.ncbi.nlm.nih.gov/19544527/
5. Yang, Nanyan, Liu, Zhihong, Pang, Shiyu, Liang, Junguang, Sun, Li. 2020. Predicative value of IFITM2 in renal clear cell carcinoma: IFITM2 is associated with lymphatic metastasis and poor clinical outcome. In Biochemical and biophysical research communications, 534, 157-164. doi:10.1016/j.bbrc.2020.11.124. https://pubmed.ncbi.nlm.nih.gov/33308825/
6. Zhang, Yongtao, Li, Xiangdong, Zhang, Shanshan, Lu, Yanqin, Han, Jinxiang. . Role of IFITM2 in osteogenic differentiation of C3H10T1/2 mesenchymal stem cells. In Intractable & rare diseases research, 13, 42-50. doi:10.5582/irdr.2023.01108. https://pubmed.ncbi.nlm.nih.gov/38404731/
智鼠故事 
